|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
|||||||||||||||
|
|||||||||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=sB389E38C-56EC-11EF-9A00-320385CE164B&I=39IZM&T=&OP=Display&O=html&O1=14747070&O2=954925415942&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DDesign%2520and%2520Biological%2520Activity%2520of%2520%2528S%2529-4-%25285-%257B%255B1-%25283-Chlorobenzyl%2529-2-%2520oxopyrrolidin-3-ylamino%255Dmethyl%257Dimidazol-1-ylmethyl%2529benzonitrile%252C%2520a%25203-Aminopyrrolidinone%2520Farnesyltransferase%2520Inhibitor%2520with%2520Excellent%2520Cell%2520Potency%26rft.au%3DABRAMS%252C%2520Marc%26rft.au%3DBELL%252C%2520Ian%2520M.%26rft.au%3DBESHORE%252C%2520Douglas%2520C.%26rft.au%3DGALLICCHIO%252C%2520Steven%2520N.%26rft.date%3D2001-08-30%26rft.eissn%3D1520-4804%26rft.epage%3D2949%26rft.externalDBID%3Dn%252Fa%26rft.externalDocID%3Dark_67375_TPS_GB9GDB4K_D%26rft.genre%3Darticle%26rft.issn%3D0022-2623%26rft.issue%3D18%26rft.jtitle%3DJournal%2520of%2520medicinal%2520chemistry%26rft.pub%3DAmerican%2520Chemical%2520Society%26rft.spage%3D2933%26rft.volume%3D44%26rft_id%3Dinfo%253Adoi%252F10.1021%252Fjm010156p%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-AMERICAN_CHEMICAL_SOCIETY_JOURNALS_IJS_KILJ_LCL-getFullTxt-object,2-AMERICAN_CHEMICAL_SOCIETY_JOURNALS_PNG_LCL-getFullTxt-object,3-DOI-getDOI-object,4-COBIB_SI_LCL-getHolding-object,5-ELSEVIER_SCOPUS_FIS_LCL-getAbstract-object,6-NCBI_PUBMED_FREE-getAbstract-object,7-ISI_WEB_OF_SCIENCE-getAuthor-object,8-ISI_JOURNAL_CITATION_REPORTS_SCIENCE_EDITION-getCitedJournal-object,9-REFWORKS_EXPORT_TOOL-getReference-object,10-SHERPA_RoMEO_LCL-getWebService-object,11-GOOGLE_SCHOLAR_FREE-getWebSearch-object,12-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=1.442951&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:14747070-sB389E38C-56EC-11EF-9A00-320385CE164B" timestamp="2024-08-10T09:46:50Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:954925415942</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>Design and Biological Activity of (S)-4-(5-{[1-(3-Chlorobenzyl)-2- oxopyrrolidin-3-ylamino]methyl}imidazol-1-ylmethyl)benzonitrile, a 3-Aminopyrrolidinone Farnesyltransferase Inhibitor with Excellent Cell Potency</jnl:atitle>
<jnl:jtitle>Journal of Medicinal Chemistry</jnl:jtitle>
<jnl:date>2001-08-01</jnl:date>
<jnl:spage>2933</jnl:spage>
<jnl:epage>2949</jnl:epage>
<jnl:coden>JMCMAR</jnl:coden>
<jnl:issn>0022-2623</jnl:issn>
<jnl:volume>44</jnl:volume>
<jnl:issue>18</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>1520-4804</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:coden>JMCMAR</jnl:coden>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:5235f4e315ffa7f97b54ccc5516c6182aab17f0b</ctx:identifier>
<ctx:identifier>urn:UUID:sB389E38C-56EC-11EF-9A00-320385CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)